What is CVE-2021-3029?

CVE-2021-3029 is a critical-severity vulnerability in Evolucare Ecs Imaging, classified under OS Command Injection. CVSS score: 9.8/10. Published 2021-01-07.

How severe is CVE-2021-3029?

Critical severity. CVSS v3 base score is 9.8 out of 10.

Is CVE-2021-3029 known to be exploited?

6 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

RCE in Evolucare Ecs Imaging

CVE-2021-3029

EVOLUCARE ECSIMAGING (aka ECS Imaging) through 6.21.5 has an OS Command Injection vulnerability via shell metacharacters and an IFS manipulation. The parameter "file" on the webpage /showfile.php can be exploited to gain root access. NOTE: This vulnerability only affects products that are no longer supported by the maintainer

Vulnerability class: Command Injection (OS Command Injection)

EPSS: 0.030 (86.1th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

Affected products

Evolucare Ecs_imaging
N/a — versions n/a

Weakness classification (CWE)

CWE-78 — OS Command Injection

Public proof-of-concept exploits

References

cve@mitre.org (Product, x_refsource_MISC)
cve@mitre.org (Third Party Advisory, x_refsource_MISC)

Frequently asked questions

What is CVE-2021-3029?: CVE-2021-3029 is a critical-severity vulnerability in Evolucare Ecs Imaging, classified under OS Command Injection. CVSS score: 9.8/10. Published 2021-01-07.
How severe is CVE-2021-3029?: Critical severity. CVSS v3 base score is 9.8 out of 10.
Is CVE-2021-3029 known to be exploited?: 6 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.